A high uptake on somatostatin receptor imaging (SRI) was seen for 39% of NEC, although only performed in 1/5 of NEC cases and 1/3 of NEC with an SRI uptake had Ki-67 < 55%. This evidence concerns the gene MKI67 and neuroendocrine carcinoma.